Real-time enrollment status for this refractory non-hodgkin lymphoma clinical trial
Current Status
Recruiting
Checked: September 1, 2026 at 9:26 PM UTC
| NCT Number | NCT05260957 |
| Recruiting Status | Recruiting |
| Condition | Refractory Non-Hodgkin Lymphoma |
| Phase | PHASE2 |
| Target Enrollment | 22 participants |
| Active Locations | 1 sites in the US |
| Sponsor | Lazaros Lekakis |
| Last Updated on CT.gov | December 31, 2025 (Dec 31, 2025) |
As of September 1, 2026: Clinical trial NCT05260957 is currently recruiting participants. This phase2 study for refractory non-hodgkin lymphoma is actively seeking new participants at 1 location across the United States. The study is sponsored by Lazaros Lekakis. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT05260957 is actively recruiting participants as of September 1, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05260957 was last updated Dec 31, 2025 (December 31, 2025). HelloStudys verifies this status automatically.